Patents

  • Simon C, Medrano JV, Pellicer A. Direct conversion of human somatic cells to meiotic germ-like cells by genetics reprogramming. Ref: 62/048,493. Owner: Igenomix SL.
  • Simon C, Santamaría X, Cervelló I, Pellicer A. Stem cell theraphy in endometrial pathologies. Ref: 62/013,121. Owner: Igenomix SL
  • Simon C, Garrido-Gómez T, Pellicer A. Early detection of preeclampsia. Ref: USSN 61/969,520. Owner: Igenomix SL
  • Simon C, Horcajadas JA, Diaz-Gimeno P, Pellicer A. Gene Expression profile as an endometrial receptivity marker. Ref: PCT/ES2009/000386. Owner: Igenomix SL
  • Simon C, Pellicer A, Berlanga O. Diagnostic method for endometrial receptivity. Ref: PCT/EP2011/050867; EP10382011.4. Owner: Igenomix SL.
  • Sánchez Madrid F, Yañez Mo M, Domínguez F, Simon C. Use of CD98 as endometrial receptivity marker. Ref: P200902193. Owner: Fundación IVI, UAMD – Universidad Autónoma de Madrid / CNIC – Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
  • Pellicer A, Simon C, Gómez R. The use of dopamine agonist to prevent ovarian hyperstimulation. Ref: 80/138645. Owner: Fundación Instituto Valenciano de Infertilidad, sold to Ferring S.A.
  • Pellicer A, Simon C, Novella E. The use of dopamine agonist to treat endometriosis. Ref: 78/659453. Owner: Fundación Instituto Valenciano de Infertilidad, sold to Ferring S.A.
  • Simon C, Blesa D, Pellicer A. Massive failure Diagnosis of the mature oocyte generation in controlled ovarian stimulation treatments. Ref: EP12382032.6. Owner: Igenomix SL.
  • Simon C, Ruiz-Vela A, Aguilar-Gallardo C. Methods for tumor treatment and adipogenesis differentiation. Ref: US 13/251,529. Owner: Centro de Investigación Príncipe Felipe.
  • Krtolica A, Simon C, Foulk R. Methods and compositions relating to embryonic stem cell lines. Ref: US2005/046953. Owner: StemLifeLine, Inc.
  • Krtolica A, Simon C, Foulk R. Methods and systems relating to embryonic stem cell lines. Ref: US2005/047178. Owner: StemLifeLine, Inc.
  • Polan ML, Simon C. Interleukin-1 receptor antagonist (IL-1ra) as a new method of contraception. Ref: 08/136,077. Owner: Personal.